At a glance

ClinicalIndex Comparison Record

N/ACompleted· 62 enrolled

Drug / intervention

UltraShape Powerdevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02748928

NCT02748928N/ACompleted

Compare CT.gov

Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Power Device Using the U-Sculpt Power Transducer for Abdominal Fat and Circumference Reduction

Syneron Medical·interventional·Posted Apr 22, 2016·Updated Mar 19, 2019

In Brief

A clinical study evaluating UltraShape Power for Excess Abdominal Fat. Completed, enrolled 62 participants across 8 sites.

Detailed Summary

Prospective, one arm, baseline-controlled, clinical study for the evaluation of the UltraShape Power treatment using the U-Sculpt Power Transducer for non-invasive abdominal fat and circumference reduction.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsExcess Abdominal Fat

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

First PostedApr 2016

Enrollment StartJun 2016

Primary CompletionFeb 2017

Study CompletionApr 2018

TodayJul 2026

First PostedApr 22, 2016

Enrollment StartJun 8, 2016

Primary CompletionFeb 15, 2017

Study CompletionApr 23, 2018

TodayJul 2, 2026

Enrollment to primary: 8 monthsPosted 10.2 years ago

Interventions

UltraShape Powerdevice

Tissue selectivity is achieved by a proprietary knowledge of ultrasound parameters ensuring specific destruction of the fat cells only within the target area. All other types of tissue, such as blood vessels, muscles and peripheral nerves remain intact. There are no thermal effects. Fat cell destruction is achieved by ultrasound-induced mechanical effects during a very short exposure time